Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Immunocore Ltd
Merck Sharp & Dohme LLC
Genmab
Seagen Inc.
Dana-Farber Cancer Institute
Mayo Clinic
Aminex Therapeutics, Inc.
Ohio State University Comprehensive Cancer Center
University of California, Irvine
Emory University
Pfizer
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Genmab
Neonc Technologies, Inc.
Institute of Oncology Ljubljana
Immunocore Ltd
Ohio State University Comprehensive Cancer Center
Bayer
Duke University
Institute of Oncology Ljubljana
Melanoma Institute Australia
Tizona Therapeutics, Inc
BioInvent International AB
Essen Biotech
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Genentech, Inc.
Shanghai Henlius Biotech
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
Sandoz
University of California, Davis
Teva Branded Pharmaceutical Products R&D, Inc.
Instituto do Cancer do Estado de São Paulo
City of Hope Medical Center
Vastra Gotaland Region
Mayo Clinic
ImmunityBio, Inc.
NuCana plc
M.D. Anderson Cancer Center
University of Southern California
Novartis
Bayer
Brown University
Syntrix Biosystems, Inc.